Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcomaAviv Regev, Cyril Neftel, Marni E. Shore et al.|Nature Medicine|2021Cited by 127
COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesisYu Zheng, Daniel A. Haber, Srinjoy Sil et al.|Proceedings of the National Academy of Sciences|2019Cited by 48
Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathwaysS. Michael Rothenberg, Daniel A. Haber, Kyle Concannon et al.|eLife|2015Cited by 45
Author response: Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathwaysS. Michael Rothenberg, Daniel A. Haber, Kyle Concannon et al.|Unknown|2015Cited by 0